HIVE Blockchain Valuation

HIVE Stock  CAD 5.20  0.31  5.63%   
At this time, the firm appears to be overvalued. HIVE Blockchain Tech retains a regular Real Value of C$4.44 per share. The prevalent price of the firm is C$5.2. Our model calculates the value of HIVE Blockchain Tech from analyzing the firm fundamentals such as return on asset of -0.0847, and Return On Equity of -0.0736 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting HIVE Blockchain's valuation include:
Price Book
1.8953
Enterprise Value
735.4 M
Enterprise Value Ebitda
9.498
Price Sales
5.7796
Forward PE
84.7458
Overvalued
Today
5.20
Please note that HIVE Blockchain's price fluctuation is risky at this time. Calculation of the real value of HIVE Blockchain Tech is based on 3 months time horizon. Increasing HIVE Blockchain's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the HIVE stock is determined by what a typical buyer is willing to pay for full or partial control of HIVE Blockchain Technologies. Since HIVE Blockchain is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HIVE Stock. However, HIVE Blockchain's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  5.2 Real  4.44 Hype  5.04
The intrinsic value of HIVE Blockchain's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence HIVE Blockchain's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
4.44
Real Value
10.39
Upside
Estimating the potential upside or downside of HIVE Blockchain Technologies helps investors to forecast how HIVE stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HIVE Blockchain more accurately as focusing exclusively on HIVE Blockchain's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
0.255.0410.99
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use HIVE Blockchain's intrinsic value based on its ongoing forecasts of HIVE Blockchain's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against HIVE Blockchain's closest peers.

HIVE Blockchain Cash

5.59 Million

HIVE Valuation Drivers Correlation

Many accounts on the financial statements of HIVE Blockchain Tech are highly interrelated and sometimes correlated. Consequently, when conducting HIVE's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of HIVE
Click cells to compare fundamentals

HIVE Valuation Trend

Analysing the historical paterns of HIVE Blockchain's enterprise value and its market capitalization is a good way to estimate and gauge the value of HIVE Blockchain Technologies over time and is usually enough for investors to make rational market timing decisions.

HIVE Blockchain Total Value Analysis

HIVE Blockchain Technologies is currently anticipated to have takeover price of 735.38 M with market capitalization of 711.02 M, debt of 30.72 M, and cash on hands of 1.3 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the HIVE Blockchain fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
735.38 M
711.02 M
30.72 M
1.3 M

HIVE Blockchain Investor Information

About 24.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. HIVE Blockchain Tech recorded a loss per share of 0.18. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 24th of May 2022. Based on the analysis of HIVE Blockchain's profitability, liquidity, and operating efficiency, HIVE Blockchain Technologies is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in December.

HIVE Blockchain Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. HIVE Blockchain has an asset utilization ratio of 37.21 percent. This indicates that the Company is making C$0.37 for each dollar of assets. An increasing asset utilization means that HIVE Blockchain Technologies is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

HIVE Blockchain Ownership Allocation

HIVE Blockchain Technologies has a total of 129.04 Million outstanding shares. Roughly 75.3 (percent) of HIVE Blockchain outstanding shares are held by general public with 0.45 % owned by insiders and only 24.25 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

HIVE Blockchain Profitability Analysis

The company reported the revenue of 114.47 M. Net Loss for the year was (51.2 M) with profit before overhead, payroll, taxes, and interest of 163.93 M.

About HIVE Blockchain Valuation

Our relative valuation model uses a comparative analysis of HIVE Blockchain. We calculate exposure to HIVE Blockchain's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of HIVE Blockchain's related companies.
Last ReportedProjected for Next Year
Gross Profit-29 M-27.5 M
Pretax Profit Margin(0.39)(0.41)
Operating Profit Margin 0.17  0.18 
Net Loss(0.45)(0.47)
Gross Profit Margin 0.35  0.37 

Additional Tools for HIVE Stock Analysis

When running HIVE Blockchain's price analysis, check to measure HIVE Blockchain's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HIVE Blockchain is operating at the current time. Most of HIVE Blockchain's value examination focuses on studying past and present price action to predict the probability of HIVE Blockchain's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HIVE Blockchain's price. Additionally, you may evaluate how the addition of HIVE Blockchain to your portfolios can decrease your overall portfolio volatility.